SMAD4 and intrahepatic cholangiocarcinoma: However, the role in hepatoma is not clear due to the fact that Smad4 overexpression has been reported in patients with extrahepatic cholangiocarcinoma, while reduced expression has been found in patients with intrahepatic cholangiocarcinoma.